J P Morgan Chase & Co set a €106.40 ($123.72) price target on Fresenius Medical Care AG & Co. KGaA (ETR:FME) in a research note issued to investors on Thursday. The brokerage currently has a buy rating on the stock.

Other research analysts also recently issued research reports about the stock. UBS AG set a €68.00 ($79.07) price target on shares of Fresenius Medical Care AG & Co. KGaA and gave the stock a sell rating in a research note on Wednesday, May 3rd. Citigroup Inc. set a €92.00 ($106.98) price target on shares of Fresenius Medical Care AG & Co. KGaA and gave the stock a buy rating in a research note on Friday, June 9th. Berenberg Bank set a €95.00 ($110.47) price target on shares of Fresenius Medical Care AG & Co. KGaA and gave the stock a buy rating in a research note on Friday, June 30th. S&P Global set a €88.00 ($102.33) price target on shares of Fresenius Medical Care AG & Co. KGaA and gave the stock a neutral rating in a research note on Wednesday, May 3rd. Finally, Independent Research GmbH set a €90.00 ($104.65) price target on shares of Fresenius Medical Care AG & Co. KGaA and gave the stock a neutral rating in a research note on Wednesday, May 3rd. Two analysts have rated the stock with a sell rating, ten have assigned a hold rating and eleven have assigned a buy rating to the stock. The stock has a consensus rating of Hold and an average price target of €87.98 ($102.30).

Shares of Fresenius Medical Care AG & Co. KGaA (ETR FME) opened at 80.802 on Thursday. The company’s 50-day moving average is €85.14 and its 200-day moving average is €80.97. The stock has a market cap of €24.75 billion and a PE ratio of 19.727. Fresenius Medical Care AG & Co. KGaA has a 52-week low of €70.82 and a 52-week high of €89.07.

COPYRIGHT VIOLATION NOTICE: This story was first reported by Watch List News and is the property of of Watch List News. If you are viewing this story on another website, it was illegally copied and reposted in violation of international trademark and copyright legislation. The correct version of this story can be viewed at https://www.watchlistnews.com/fresenius-medical-care-ag-106-40-price-target-at-j-p-morgan-chase-co/1463019.html.

About Fresenius Medical Care AG & Co. KGaA

Fresenius Medical Care AG & Co KGaA is a kidney dialysis company. The Company provides dialysis care and related services to persons suffering from end-stage renal disease (ESRD), as well as other healthcare services. The Company’s segments include North America Segment, the Europe, Middle East and Africa (EMEA) Segment, the Asia-Pacific Segment and the Latin America Segment.

Analyst Recommendations for Fresenius Medical Care AG & Co. KGaA (ETR:FME)

Receive News & Ratings for Fresenius Medical Care AG & Co. KGaA Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Fresenius Medical Care AG & Co. KGaA and related companies with Analyst Ratings Network's FREE daily email newsletter.